Interplay between vaccine-related informational milestones, social media discourse, and vaccine administration rates for human papillomavirus and measles/mumps/rubella vaccines in the United States. [PDF]
Annan A +6 more
europepmc +1 more source
Safety and immunogenicity of live attenuated vaccines during corticosteroid therapy in children with nephrotic syndrome: protocol for an open-label, non-inferiority, randomised controlled trial (VACCINES trial: VAccines in Children on CorticosteroIds for NEphrotic Syndrome). [PDF]
Mathew G +11 more
europepmc +1 more source
Rubella outbreak investigation in Adigrat town of Eastern Tigray, Northern Ethiopia, 2024: case-control study design. [PDF]
Teklu MW, Nigusse AT.
europepmc +1 more source
Measles-rubella surveillance and its facilitators and barriers in Bagmati province, Nepal: a mixed methods study. [PDF]
Shrestha B +10 more
europepmc +1 more source
European Immunization Week: two decades of raising awareness and building momentum for the global campaign ahead. [PDF]
Kluge H.
europepmc +1 more source
Evaluation of Coverage Rates of 3 Pediatric Vaccines (Measles-Mumps-Rubella, Hexavalent, and Varicella) in a Southern Italian Province (2016-2022): Effect of the Pandemic and Interregional Comparisons. [PDF]
Santoro E +10 more
europepmc +1 more source
Two-dose measles vaccination in a post-elimination era: lessons from Japan's 2026 school outbreak. [PDF]
Kaneda Y, Kami M.
europepmc +1 more source
Combination Vaccines in Routine Childhood Immunization Programs - Worldwide, 2024. [PDF]
Zheng F +4 more
europepmc +1 more source
Immune and non-immune hydrops fetalis in a resource-limited setting: a report of two cases. [PDF]
Ochieng WO +3 more
europepmc +1 more source

